TABLE 1

Patient Profiles: Demographic Features and Clinical and Stimulation Characteristics

Patient no.	Age at ACaS (y)	Sex	Disease duration (y)			Stimulus parameters	Electrode location	Preoperative scores
Patient no.	Age at ACaS (y)	Sex	Disease duration (y)	Medication	Stimulation	Stimulus parameters	Electrode location	Y-BOCS	HAM-D	BDI
1	34	M	23	Lormetazepam (0.5 mg/d)	Bilateral	0−1−2−3+	ACa	38	43	48
2	52	F	28	Sertraline (150 mg/d), prazepam (60 mg/d), diazepam (10 mg/d), trazodone (100 mg/d)	Bilateral	0+1−2+	ACa	33	23	39
3	38	F	22	Fluoxetine (20 mg/d), clomipramine (50 mg/d), lorazepam (3.75 mg/d)	Bilateral	0−1−2−3−C+	ACa	30	29	35
4	40	F	26	Fluoxetine (40 mg/d), thioridazine (50 mg/d), alprazolam (4 mg/d)	Bilateral	0+1−	ACa + MD (not stimulated)	34	19	41
5	38	M	21	Clomipramine (225 mg/d), olanzapine (20 mg/d)	Bilateral	0−1+	ACa	30	24	38
6	40	F	19	Clomipramine (75 mg/d)	Right	0−1+	ACa	35	16	27

ACaS = anterior capsular stimulation; ACa = anterior limb of internal capsule; MD = mediodorsal thalamic nucleus.